Andrew E. Place

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 302 citations · Full text

Knockout Mouse, Xenotransplantation, Xenografts Enables Discovery +9

A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity.

Nanjoo Suh, Yongping Wang, Tadashi Honda et al. · PubMed · 1999 · 283 citations

Chemoprevention Strategy, Immunology, Cell Death +21

The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling

Karen T. Liby, Thomas Hock, Mark M. Yore et al. · Cancer Research · 2005 · 281 citations · Full text

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman et al. · The Lancet Oncology · 2015 · 234 citations

Medicine, Microbiology, Open-label Phase 3 +1

The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.

Andrew E. Place, Nanjoo Suh, Charlotte R. Williams et al. · PubMed · 2003 · 147 citations

Immunology, Leukemia Cells, U937 Leukemia Cells +18